Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Sionna Therapeutics

Tracked across 2 events · 30 articles · First seen Aug 10, 2026 · Last active Sep 03, 2026

Sentiment
-48
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -95
Business
On August 10, 2026, Sionna Therapeutics announced that its Phase 2a PreciSION CF trial of SION-719, an investigational cystic fibrosis treatment, failed to achieve its key activity endpoint of sweat chloride reduction when added to…
Impact: Sionna Therapeutics is the central entity; its Phase 2a trial failure caused a 91% stock price collapse and triggered securities investigations. The company faces potential legal claims and reputational damage.
Aug 12, 2026 · 24 articles
1 0
Business
Impact: Sionna Therapeutics is mentioned as Ridloff's current employer, but is not directly affected by this event.
Aug 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Sionna Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.